ResMed Capital Expenditure Trend

RMD -- USA Stock  

USD 105.80  0.96  0.90%

This module enables investors to look at ResMed various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 414.6 M, Cost of Revenue of 908.5 M or Earning Before Interest and Taxes EBIT of 530.3 M, but also many exotic indicators such as Long Term Debt to Equity of 0.6074, Calculated Tax Rate of 23.327 or PPandE Turnover of 5.5886. This module is a perfect complement to use when analyzing ResMed Valuation or Volatility. It can also complement various ResMed Technical models. Additionally take a look at analysis of ResMed Correlation with competitors.
Showing smoothed Capital Expenditure of ResMed with missing and latest data points interpolated. A component of Net Cash Flow from Investing representing the net cash inflow (outflow) associated with the acquisition & disposal of long-lived, physical & intangible assets that are used in the normal conduct of business to produce goods and services and are not intended for resale. Includes cash inflows/outflows to pay for construction of self-constructed assets & software.
Capital Expenditure10 Years Trend
Decreasing
Stable
 Capital Expenditure 
      Timeline 

Regression Statistics

Arithmetic Mean (61,563,348)
Coefficient Of Variation (29.24)
Mean Deviation  11,203,760
Median (58,534,000)
Standard Deviation  18,002,592
Range  80,470,000
R Value (0.13)
R Squared  0.017278
Significance  0.67
Slope (607,622)

ResMed Capital Expenditure Over Time

2016-12-31 (58,534,000) 
2017-12-31 (58,534,000) 
2018-12-31 (68,863,529) 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  

Upcoming Events

ResMed Upcoming Company Events
Upcoming Quarterly ReportApril 25, 2017
Next Earnings ReportJuly 27, 2017
Additionally take a look at analysis of ResMed Correlation with competitors. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.